Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has provided an announcement.
Jiangsu Recbio Technology Co., Ltd. has received approval from the China Securities Regulatory Commission (CSRC) for the issuance of domestic shares to a target subscriber. This approval is valid for 12 months and requires the company to adhere strictly to the submitted filing documents. The issuance is subject to certain conditions and uncertainties, and the company will provide further updates as necessary. Shareholders and potential investors are advised to exercise caution when dealing with the company’s securities.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology industry. The company focuses on the development and issuance of domestic shares, with a market focus on expanding its shareholder base and enhancing its capital structure.
Average Trading Volume: 125,921
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.02B
See more data about 2179 stock on TipRanks’ Stock Analysis page.